東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Molecular Co-Evolution Between SARS-...

Moulana, Alief,

Linked to FindBook

Google Book

Amazon

博客來

Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies // Alief Moulana.
Author:	Moulana, Alief,
Description:	1 electronic resource (123 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
Contained By:	Dissertations Abstracts International86-12B.
Subject:	Biology. -
Online resource:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32040550
ISBN:	9798280717008

Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies /
Moulana, Alief,

Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies /Alief Moulana. - 1 electronic resource (123 pages)

Source: Dissertations Abstracts International, Volume: 86-12, Section: B.

The COVID-19 pandemic disrupted global health systems but simultaneously offered a rare opportunity to observe the rapid co-evolution of a virus, SARS-CoV-2, with the human immune system in real time. This evolutionary interplay is often thought of as a molecular arms race, in which both pathogen and host must continually adapt to changes in each other's phenotype. This dynamic is particularly pronounced at the molecular recognition level. Human antibodies evolve (via affinity maturation) to better neutralize the viral antigens (e.g., SARS-CoV-2 spike protein), while the virus, in turn, accumulates mutations that confer immune escape. In this dissertation, I present four projects that explore the co-evolutionary landscape between viral and immune proteins. Chapters 1 and 2 focus on the combinatorial mutagenesis of the SARS-CoV-2 spike receptor-binding domain (RBD) to measure the individual and combined effects of Omicron BA.1 mutations on ACE2 binding affinity (Chapter 1) and antibody evasion (Chapter 2). Chapter 3 extends this approach to later Omicron subvariants, using high-throughput genotype-to-phenotype mapping to investigate how mutational effects depend on genetic background across divergent lineages. Finally, Chapter 4 shifts focus to the host immune response, using deep sequencing of human peripheral blood B cell repertoires and yeast display of candidate antibodies to measure evolving antibody phenotypes. Together, these studies provide an integrated view of viral and immune co-evolution, inferring the molecular principles that govern host-pathogen interactions and the trajectory of viral adaptation.

English

ISBN: 9798280717008Subjects--Topical Terms:

522710
Biology.
Subjects--Index Terms:

B cell

Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies /
LDR:03064nmm a22004333i 4500 001 2433859
005 20250905091029.5
006 m o d
007 cr|nu||||||||
008 261011s2025 miu||||||m |||||||eng d
020 $a 9798280717008
035 $a (MiAaPQD)AAI32040550
035 $a AAI32040550
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Moulana, Alief, $e author. $0 (orcid)0000-0002-0389-7082 $3 3823631
245 1 0 $a Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies / $c Alief Moulana.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (123 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
500 $a Advisors: Desai, Michael Committee members: Chakraborty, Arup; Cavanaugh, Colleen; Edwards, Scott.
502 $b Ph.D. $c Harvard University $d 2025.
520 $a The COVID-19 pandemic disrupted global health systems but simultaneously offered a rare opportunity to observe the rapid co-evolution of a virus, SARS-CoV-2, with the human immune system in real time. This evolutionary interplay is often thought of as a molecular arms race, in which both pathogen and host must continually adapt to changes in each other's phenotype. This dynamic is particularly pronounced at the molecular recognition level. Human antibodies evolve (via affinity maturation) to better neutralize the viral antigens (e.g., SARS-CoV-2 spike protein), while the virus, in turn, accumulates mutations that confer immune escape. In this dissertation, I present four projects that explore the co-evolutionary landscape between viral and immune proteins. Chapters 1 and 2 focus on the combinatorial mutagenesis of the SARS-CoV-2 spike receptor-binding domain (RBD) to measure the individual and combined effects of Omicron BA.1 mutations on ACE2 binding affinity (Chapter 1) and antibody evasion (Chapter 2). Chapter 3 extends this approach to later Omicron subvariants, using high-throughput genotype-to-phenotype mapping to investigate how mutational effects depend on genetic background across divergent lineages. Finally, Chapter 4 shifts focus to the host immune response, using deep sequencing of human peripheral blood B cell repertoires and yeast display of candidate antibodies to measure evolving antibody phenotypes. Together, these studies provide an integrated view of viral and immune co-evolution, inferring the molecular principles that govern host-pathogen interactions and the trajectory of viral adaptation.
546 $a English
590 $a School code: 0084
650 4 $a Biology. $3 522710
650 4 $a Immunology. $3 611031
650 4 $a Virology. $3 642304
653 $a B cell
653 $a Binding affinity
653 $a Evolution
653 $a Genotype-to-phenotype map
653 $a Molecular recognition
690 $a 0306
690 $a 0982
690 $a 0720
710 2 $a Harvard University. $b Biology, Organismic and Evolutionary. $e degree granting institution. $3 3823632
720 1 $a Desai, Michael $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-12B.
790 $a 0084
791 $a Ph.D.
792 $a 2025
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32040550